Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake

Dow Jones

2025/06/26

By Colin Kellaher

Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount.

Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84.

Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading.

Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests.

Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility.

The company said it also may buy back up to $15 million worth of the shares Fosun is selling.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

June 26, 2025 07:29 ET (11:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2546782734"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546782734\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546782734?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-26 19:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546782734","market":"sg","top_or_hot":-1,"title":"Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n</p>\n<p>\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n</p>\n<p>\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n</p>\n<p>\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n</p>\n<p>\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n</p>\n<p>\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2025 07:29 ET (11:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-06-26 19:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n</p>\n<p>\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n</p>\n<p>\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n</p>\n<p>\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n</p>\n<p>\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n</p>\n<p>\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2025 07:29 ET (11:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0196","symbol_name":"行业龙头","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2546782734","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546782734","pubTimestamp":1750937340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount.Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84.Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading.Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests.Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility.The company said it also may buy back up to $15 million worth of the shares Fosun is selling.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","BK0196":"行业龙头","BK0239":"医药制造","BK0096":"民营医院","BK1543":"农业股票概念","BK1113":"化肥与农用药剂","BK0183":"MSCI概念","BK4183":"个人用品","02196":"复星医药","BK0188":"融资融券","BK0012":"证金概念","NATR":"天然阳光产品","BK0187":"一线龙头","BK0028":"国家队","BK1191":"制药","BK1593":"医美概念股","BK0175":"白马股","00656":"复星国际","00509":"世纪阳光(新)","BK0060":"抗癌","BK1230":"工业集团企业","BK1515":"抗疫概念"},"translate_title":"上海复星出售股份后，大自然阳光股价盘前下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9,"00509":1,"NATR":0.9,"02196":0.9,"00656":1},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n\n\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n\n\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n\n\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n\n\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n\n\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2025 07:29 ET (11:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}